Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells (Q40729379)

23 September 2017

Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells (English)

1 reference

23 September 2017

Abhik Bandyopadhyay

1

1 reference

23 September 2017

Yong Zhu

2

1 reference

23 September 2017

Shazli N Malik

3

1 reference

23 September 2017

Jeffrey Kreisberg

4

1 reference

23 September 2017

Michael G Brattain

5

1 reference

23 September 2017

Eugene A Sprague

6

1 reference

23 September 2017

Jian Luo

7

1 reference

23 September 2017

Fernando López-Casillas

8

1 reference

23 September 2017

L-Z Sun

9

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

23 September 2017

1 reference

23 September 2017

21

1 reference

23 September 2017

22

1 reference

23 September 2017

3541-3551

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205439

23 September 2017

0 references

cites work

Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Heterogeneity of human colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Expression of transforming growth factor beta (TGFbeta) type III receptor restores autocrine TGFbeta1 activity in human breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Expression of scatter factor in human bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Tumor suppressor activity of the TGF-beta pathway in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor β and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Metastasis from human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Expression of transforming growth factor beta type III receptor suppresses tumorigenicity of human breast cancer MDA-MB-231 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205439

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205439

1 reference

Dimensions Publication ID

23 September 2017

0 references

1 reference